Skip to main content
. 2021 Feb;10(1):9–19. doi: 10.21037/hbsn.2019.09.02

Table 1. Characteristics of patients in the training and validation cohort.

Characteristics Training cohort, n=321 Validation cohort, n=501
Recipient age (years) 49.58 (15.29) 52.17 (13.79)
Recipient sex
   Male 273 (85.05) 413 (82.44)
   Female 48 (14.95) 88 (17.56)
Recipient BMI 22.84 (3.56) 22.58 (4.09)
High MELD
   No 91 (28.35) 206 (41.12)
   Yes 230 (71.65) 295 (58.88)
Operative time (h) 5.13 (1.23) 5.67 (2.27)
CIT (h) 9.53 (4.99) 8.00 (3.07)
Donor age (years) 41.33 (21.29) 49.17 (18.33)
Donor sex
   Male 269 (83.80) 406 (81.04)
   Female 52 (16.20) 95 (18.96)
Graft weight (g) 1,340.00 (348.00) 1,320.00 (375.00)
GRWR (%) 2.05 (0.72) 2.02 (0.73)
EAD incidence
   EAD 149 (46.42) 203 (40.52)
   Non-EAD 172 (53.58) 298 (59.48)

EAD, early allograft dysfunction; GRWR, graft-to-recipient weight ratio; LT, liver transplant; MELD, Model for End-stage Liver Disease; CIT, cold ischemia time. High MELD, preoperative MELD score >30.